Table 1. Characteristics and laboratory values of participants at time of cancer staging.
| Variable | All (240) | Survived (173) | Deceased (67) | P-value |
|---|---|---|---|---|
| Age (yrs) | 59 (13) | 59 (13) | 61 (15) | 0.26 |
| Female sex, n (%) | 73 (30) | 52 (30) | 21 (31) | 0.97 |
| Body Mass Index (kg/m2) | 27.3 (5.7) | 27.4 (5.7) | 27.1 (5.8) | 0.70 |
| Psychiatric History, n (%) | ||||
| Depression | 33 (13) | 23 (13) | 10 (14) | 0.64 |
| Anti-depressant medication | 29 (12) | 19 (11) | 10 (15) | 0.54 |
| Anti-anxiety medication | 48 (20) | 37 (21) | 11 (16) | 0.49 |
| Cardiovascular risk factors, n (%) | ||||
| Diabetes | 26 (10) | 17 (9) | 9 (13) | 0.57 |
| Hypertension | 113 (47) | 79 (45) | 34 (50) | 0.57 |
| Dyslipidemia | 64 (26) | 43 (24) | 21 (31) | 0.39 |
| Smoking | 158 (65) | 107 (61) | 51 (76) | 0.05 |
| Mean ASCVD 10-year risk | 12 (14) | 12 (13) | 15 (16) | 0.18 |
| Heart failure | 7 (2) | 4 (2) | 3 (5) | 0.93 |
| Ischemic heart disease | 20 (8) | 16 (9) | 4 (6) | 1 |
| Myocardial infarction | 14 (5) | 8 (5) | 6 (9) | 0.57 |
| Stroke | 8 (3) | 6 (4) | 2 (3) | 0.33 |
| Laboratory Values | ||||
| Hematocrit | 38 (5) | 38 (5) | 37 (5) | 0.38 |
| Total Cholesterol (mg/dL) | 172 (28) | 173 (28) | 168 (27) | 0.91 |
| LDL (mg/dL) | 96 (26) | 98 (26) | 92 (27) | 0.21 |
| HDL (mg/dL) | 52 (13) | 52 (14) | 53 (12) | 0.12 |
| Triglycerides (mg/dL) | 166 (72) | 162 (70) | 176 (77) | 0.91 |
| Glucose (mg/dL) | 112 (39) | 112 (35) | 114 (47) | 0.7 |
| HbA1C (%) | 6 (1.1) | 5.9 (1) | 6.3 (1.3) | 0.28 |
| Sodium (mg/dL) | 138 (3) | 138 (3) | 137 (3) | 0.46 |
| Creatinine (mg/dL) | 0.93 (0.3) | 0.92 (0.2) | 0.96 (0.5) | 0.44 |
| Cardiovascular medications, n (%) | ||||
| Statins | 67 (28) | 47 (27) | 20 (30) | 0.90 |
| Beta-blockers | 59 (25) | 41 (24) | 18 (27) | 0.8 |
| Aspirin | 55 (23) | 39 (23) | 16 (24) | 0.73 |
| Angiotensin-converting enzyme inhibitor | 44 (18) | 32 (18) | 12 (17) | 0.96 |
| Angiotensin-receptor blockers | 16 (7) | 11 (6) | 5 (8) | 1 |
| Calcium channel blockers | 17 (7) | 9 (5) | 8 (12) | 0.99 |
| Coumadin | 9 (4) | 5 (3) | 4 (6) | 0.12 |